JP2019509054A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019509054A5 JP2019509054A5 JP2018554653A JP2018554653A JP2019509054A5 JP 2019509054 A5 JP2019509054 A5 JP 2019509054A5 JP 2018554653 A JP2018554653 A JP 2018554653A JP 2018554653 A JP2018554653 A JP 2018554653A JP 2019509054 A5 JP2019509054 A5 JP 2019509054A5
- Authority
- JP
- Japan
- Prior art keywords
- meditope
- antibody
- free
- meditopu
- administering
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662276803P | 2016-01-08 | 2016-01-08 | |
| US62/276,803 | 2016-01-08 | ||
| US201662317342P | 2016-04-01 | 2016-04-01 | |
| US62/317,342 | 2016-04-01 | ||
| PCT/US2017/012754 WO2017120599A1 (en) | 2016-01-08 | 2017-01-09 | Self-crosslinking antibodies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019509054A JP2019509054A (ja) | 2019-04-04 |
| JP2019509054A5 true JP2019509054A5 (enExample) | 2020-02-20 |
| JP6983808B2 JP6983808B2 (ja) | 2021-12-17 |
Family
ID=59274084
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018554653A Expired - Fee Related JP6983808B2 (ja) | 2016-01-08 | 2017-01-09 | 自己架橋性抗体 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11459397B2 (enExample) |
| EP (1) | EP3399992A4 (enExample) |
| JP (1) | JP6983808B2 (enExample) |
| KR (1) | KR20180098672A (enExample) |
| CN (1) | CN108712908A (enExample) |
| AU (1) | AU2017205343A1 (enExample) |
| CA (1) | CA3010632A1 (enExample) |
| WO (1) | WO2017120599A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3411382A4 (en) * | 2016-02-02 | 2019-10-02 | Meditope Biosciences, Inc. | Anti-egfr antibody drug conjugate |
| US20210017295A1 (en) * | 2018-03-12 | 2021-01-21 | Memorial Sloan Kettering Cancer Center | Bispecific binding agents and uses thereof |
| CN109521192B (zh) * | 2018-11-27 | 2021-07-13 | 柏荣诊断产品（上海）有限公司 | 一种提高胶乳比浊试剂检测灵敏度的方法 |
| KR20220078665A (ko) * | 2019-10-10 | 2022-06-10 | 아리조나 보드 오브 리젠츠 온 비하프 오브 아리조나 스테이트 유니버시티 | 다중특이적 면역 세포 인게이저를 발현하는 종양용해 바이러스 |
| CN114555117A (zh) * | 2019-10-12 | 2022-05-27 | 百奥泰生物制药股份有限公司 | 抗cd20抗体制剂及抗cd20抗体在治疗cd20阳性疾病中的应用 |
| AU2020396647A1 (en) * | 2019-12-06 | 2022-07-07 | Ajinomoto Co., Inc. | Method for producing peptide having physiological activity, and peptide comprising short linker |
| WO2022195092A1 (en) * | 2021-03-18 | 2022-09-22 | Cellis Ag | Ferritin variants with increased stability and complexation ability |
| TW202202521A (zh) * | 2020-03-23 | 2022-01-16 | 美商必治妥美雅史谷比公司 | 用於治療癌症之抗ccr8抗體 |
| CN115210262B (zh) * | 2020-09-29 | 2023-07-14 | 昆明赛诺制药股份有限公司 | 人源化抗-cd22重组免疫毒素及其应用 |
| CN112661828B (zh) * | 2021-01-15 | 2022-04-01 | 武汉大学 | 一种突触素的抗原肽及其抗体与应用 |
| JPWO2022158554A1 (enExample) * | 2021-01-22 | 2022-07-28 | ||
| CN115677856B (zh) * | 2021-07-29 | 2023-11-28 | 东莞市朋志生物科技有限公司 | 抗人IgM抗体及其应用 |
| JP2024025400A (ja) * | 2022-08-12 | 2024-02-26 | 浜松ホトニクス株式会社 | 膜貫通タンパク質を標的オルガネラに局在化させるためのペプチドリンカー及び局在化方法並びに局在化する融合タンパク質 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60124912T2 (de) * | 2001-09-14 | 2007-06-14 | Affimed Therapeutics Ag | Multimerische, einzelkettige, Tandem-Fv-Antikörper |
| WO2006010891A2 (en) * | 2004-07-26 | 2006-02-02 | Asterion Limited | Linkers |
| US20140127200A1 (en) * | 2008-01-03 | 2014-05-08 | The Scripps Research Institute | Multispecific Antibody Targeting and Multivalency Through Modular Recognition Domains |
| US8962804B2 (en) * | 2010-10-08 | 2015-02-24 | City Of Hope | Meditopes and meditope-binding antibodies and uses thereof |
| KR102344129B1 (ko) * | 2010-10-08 | 2021-12-30 | 시티 오브 호프 | 메디토프를 위한 단일클론 항체 프레임워크 결합 계면, 메디토프 전달 시스템 및 이의 사용 방법 |
| CN104039809A (zh) * | 2011-10-10 | 2014-09-10 | 希望之城公司 | 中间位和中间位结合抗体及其用途 |
| US9428553B2 (en) * | 2012-02-10 | 2016-08-30 | City Of Hope | Meditopes and meditope-binding antibodies and uses thereof |
| KR20170063881A (ko) * | 2014-10-02 | 2017-06-08 | 시티 오브 호프 | 다가 메디토프, 메디토프 결합 항체 및 이의 용도 |
| CA2986030A1 (en) * | 2015-05-15 | 2016-11-24 | City Of Hope | Chimeric antigen receptor compositions |
| EP3411382A4 (en) * | 2016-02-02 | 2019-10-02 | Meditope Biosciences, Inc. | Anti-egfr antibody drug conjugate |
-
2017
- 2017-01-09 AU AU2017205343A patent/AU2017205343A1/en not_active Abandoned
- 2017-01-09 KR KR1020187022826A patent/KR20180098672A/ko not_active Ceased
- 2017-01-09 US US16/068,892 patent/US11459397B2/en active Active
- 2017-01-09 WO PCT/US2017/012754 patent/WO2017120599A1/en not_active Ceased
- 2017-01-09 CN CN201780016120.2A patent/CN108712908A/zh active Pending
- 2017-01-09 CA CA3010632A patent/CA3010632A1/en active Pending
- 2017-01-09 EP EP17736526.9A patent/EP3399992A4/en not_active Withdrawn
- 2017-01-09 JP JP2018554653A patent/JP6983808B2/ja not_active Expired - Fee Related